Genscript RP11303) which was used as a negative control. Titers were determined as 367 described previously (23). Due to differences in the receptors expressed by different cell...">

Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Differential Inhibitory Effects of Cyanovirin-N, Griffithsin and Scytovirin on Entry Mediated by Envelopes of Gammaretroviruses and Deltaretroviruses.

J Virol.. 2013-11; 
Jensen SM, Ruscetti FW, Rein A, Bertolette DC, Saucedo CJ, O'Keefe BR, Jones KS. Basic Research Program, Cancer and Inflammation Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
Products/Services Used Details Operation

摘要

The antiviral lectins griffithsin (GRFT), cyanovirin-N (CV-N) and scytovirin (SVN), which inhibit several enveloped viruses including lentiviruses, were examined for their ability to inhibit entry mediated by Env proteins of delta- and gammaretroviruses. The glycoproteins from HTLV-1 were resistant to the antiviral effects of all three lectins. For gammaretroviruses, CV-N inhibited entry mediated by some but not all of the envelopes examined, whereas GRFT and SVN displayed only little or no effect.

关键词

XML 地图